Drug intelligence / Profile preview

Pilief

Development stage
Unknown
Lead developer
Charak
Administration
Oral, Topical
01

Overview

Pilief is a proprietary Ayurvedic formulation developed by Charak for the management of internal and external hemorrhoids (piles). Available in both oral tablet and topical ointment forms, Pilief contains a synergistic blend of traditional herbal ingredients—including Haritaki (Terminalia chebula), Neem (Azadirachta indica), Khadira (Acacia catechu), and Kumari (Aloe barbadensis)—that exhibit anti-inflammatory, analgesic, antiseptic, and astringent properties. The formulation helps reduce pile mass, control minor bleeding, alleviate pain and itching, and promote the healing of inflamed tissues. Additionally, the oral tablets support digestive health and act as a mild laxative to relieve constipation, which is a primary contributing factor to hemorrhoids.

Brand names
Pilief

Beyond the preview

Go deeper on Pilief.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pilief.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call